Presentation | Rusan Pharma | PDF

Rusan Pharma’s API Plant in Ankleshwar (India) Receives USFDA GMP Approval

22 Jul 2024

// FIERCE PHARMA

Rusan’s API Manufacturing Facility, Madhya Pradesh, India

05 Jan 2024

// PHARMACEUTICAL-TECHNOLOGY

Rusan Pharma opens new API facility in Pithampur with Rs 300 crore investment

27 Nov 2023

// ECONOMIC TIMES

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

CPhI Worldwide, Milan

Booth #22D92

Book a meeting

envelop Contact Supplier

DIGITAL CONTENT

22 CORPORATE CONTENT #SupplierSpotlight, 8 NEWS #PharmaBuzz

media
22 CORPORATE CONTENT #SupplierSpotlight
8 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

31 All APIs, 2 USDMF, 7 CEP/COS, 15 EU WC, 3 KDMF, 3 NDC API, 31 Listed APIs

31 All APIs
2 USDMF
7 CEP/COS
15 EU WC
3 KDMF
3 NDC API
31 Listed APIs

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers, 113 Listed Dossiers

113 FDF Dossiers
113 Listed Dossiers

KEY PRODUCTS

Apomorphine Hydrochloride, Clonazepam, Eflornithine Hydrochloride, Nalbuphine Hydrochloride, Sodium Oxybate

Apomorphine Hydrochloride
Clonazepam
Eflornithine Hydrochloride
Nalbuphine Hydrochloride
Sodium Oxybate

SERVICES

Clinical Trials, Analytical

pharmaServices
Clinical Trials
Analytical
- 3 BioAnalytical Services

KEY SERVICES

Bioanalytical Method Development & Validation, Bioanalytical - Pharmacokinetic Modeling, Clinical Trial Monitoring, Clinical Data Management, Statistical Analysis for Clinical Trials, Medical Writing for Clinical Trials, Patient Recruitment for Clinical Trials, Investigator Selection for Clinical Trials, Quality Assurance & Compliance, In-vitro & In-vivo Bioequivalence Studies

Bioanalytical Method Development & Validation
Bioanalytical - Pharmacokinetic Modeling
Clinical Trial Monitoring
Clinical Data Management
Statistical Analysis for Clinical Trials
Medical Writing for Clinical Trials
Patient Recruitment for Clinical Trials
Investigator Selection for Clinical Trials
Quality Assurance & Compliance
In-vitro & In-vivo Bioequivalence Studies

INSPECTIONS & REGISTRATIONS

1 FDA, 6 EDQM, 2 WHO-GMP, 1 Others

inspections
1 FDA
6 EDQM
2 WHO-GMP
1 Others

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

About

Rusan Pharma is a fully integrated global pharmaceutical company specializing in the treatment of addiction & pain management. We manufacture & market a wide range of APIs & formulations, in the area of controlled substances. Our facilities are GMP-approved by Health Canada, EU, TGA, ANVISA, PIC/S, WHO, Russia & SAHPRA. We have CEP approval for various APIs such as Buprenorphine, Fentanyl, Naltrexone, Methadone, Bisoprolol & we also manufacture Naloxone, Nalbuphine, Nalmefene, Apomorphine, Efflornithine & Sodium Oxybate. We also develop & manufacture various transdermal patches & long-acting formulations such as depot injections & Implants.